brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML Ophthalmic Suspension [Simbrinza]
RxNorm concept 1421456, branded drug (sbd). Prescribable name: SIMBRINZA 1 % / 0.2 % Ophthalmic Suspension.
- RxCUI
- 1421456
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1421456 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Simbrinza (brimonidine tartrate 0.2 % / brinzolamide 1 % ) Ophthalmic Suspension
Related concepts
- brinzolamide 10 MG/ML (SCDC, consists of)
- brimonidine tartrate 2 MG/ML (SCDC, consists of)
- brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML [Simbrinza] (SBDC, consists of)
- Ophthalmic Suspension (DF, has dose form)
- Simbrinza (BN, has ingredient)
- brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML Ophthalmic Suspension (SCD, tradename of)
Linked data
NDCs
- 00065414725
- 00065414727
- 00078090438
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1421456 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1421456 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1421456. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.